|
Nov 27
|
Masimo to Present in Piper Sandler 35th Annual Healthcare Conference
|
|
Nov 20
|
Masimo's (MASI) W1 Medical Watch to Boost Patient Monitoring
|
|
Nov 17
|
Masimo W1™ Medical Watch Receives FDA 510(k) Clearance for Over-the-Counter and Prescription Use
|
|
Nov 16
|
This Masimo Insider Increased Their Holding In The Last Year
|
|
Nov 14
|
Masimo's (MASI) Latest Tie-Up to Boost Patient Monitoring
|
|
Sep 7
|
Masimo to Present in Wells Fargo Healthcare Conference
|
|
Aug 9
|
Masimo (MASI) Q2 Earnings Lag Estimates, Margins Rise
|
|
Aug 9
|
Masimo (MASI) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
|
|
Aug 8
|
Masimo (MASI) Q2 Earnings Miss Estimates
|
|
Aug 8
|
Masimo Reports Second Quarter 2023 Financial Results
|
|
Aug 7
|
Investors in Masimo (NASDAQ:MASI) have unfortunately lost 43% over the last three years
|
|
Feb 3
|
Hedge fund lobby group supports shareholder rights in Masimo case
|
|
Jan 30
|
Masimo Announces the Limited Market Release of Visual Clinical Activity Monitoring (VCAM™)
|